Incannex Healthcare Inc. financial data

Symbol
IXHL on Nasdaq
Industry
Pharmaceutical Preparations
Location
401 Docklands Drive, Suite 15, Level 12, Docklands, Victoria, Australia
State of incorporation
Australia
Fiscal year end
June 30
Former names
Incannex Healthcare Ltd (to 11/29/2023)
Latest financial report
10-Q - Q4 2024 - Feb 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 247 %
Debt-to-equity 86.7 %
Return On Equity -289 %
Return On Assets -155 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 17.9M shares +12.5%
Common Stock, Shares, Outstanding 17.8M shares +37.6%
Entity Public Float 64M USD
Common Stock, Value, Issued 2K USD 0%
Weighted Average Number of Shares Outstanding, Basic 17.6M shares +11%
Weighted Average Number of Shares Outstanding, Diluted 17.6M shares +11%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 12K USD
Research and Development Expense 11.9M USD -46.4%
General and Administrative Expense 16.6M USD -32.6%
Operating Income (Loss) -28.4M USD +37.3%
Nonoperating Income (Expense) 4.65M USD -132%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -23.8M USD -12.5%
Net Income (Loss) Attributable to Parent -23.8M USD -12.5%
Earnings Per Share, Basic -1.36 USD/shares 0%
Earnings Per Share, Diluted -1.36 USD/shares 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.1M USD -85.6%
Assets, Current 10.5M USD -50.8%
Property, Plant and Equipment, Net 273K USD -51.2%
Operating Lease, Right-of-Use Asset 329K USD -29.7%
Assets 11.1M USD -50.3%
Employee-related Liabilities, Current 369K USD +11.5%
Accrued Liabilities, Current 3.07M USD +318%
Contract with Customer, Liability, Current 27K USD
Liabilities, Current 5.84M USD +83.3%
Operating Lease, Liability, Noncurrent 152K USD -49.5%
Liabilities 10.1M USD +191%
Accumulated Other Comprehensive Income (Loss), Net of Tax -3.41M USD -20%
Retained Earnings (Accumulated Deficit) -122M USD -24.2%
Stockholders' Equity Attributable to Parent 965K USD -94.9%
Liabilities and Equity 11.1M USD -50.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.19M USD +61.9%
Net Cash Provided by (Used in) Financing Activities -52K USD
Net Cash Provided by (Used in) Investing Activities -221K USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 17.8M shares +12%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.23M USD +61.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.1M USD -85.6%
Operating Lease, Liability 329K USD -30%
Depreciation 200K USD
Payments to Acquire Property, Plant, and Equipment 221K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -24.4M USD -46.2%
Lessee, Operating Lease, Liability, to be Paid 363K USD -40.4%
Property, Plant and Equipment, Gross 560K USD -7.74%
Operating Lease, Liability, Current 177K USD +4.73%
Lessee, Operating Lease, Liability, to be Paid, Year Two 45K USD -78.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 189K USD -11.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 34K USD -75.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 30K USD -40%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 7.81M USD +29.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 38K USD
Additional Paid in Capital 126M USD +5.39%
Share-based Payment Arrangement, Expense 5.71M USD -87.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%